Sign in
Taking people in United StatesNo phase

Custom-modified stent graft for aneurysms in the thoracoabdominal aorta

Tests a doctor-modified aortic stent graft in people with thoracoabdominal aortic aneurysm.

Key facts

Who runs it
Yale University
Where
Lebanon and New Haven, United StatesSee the 2 sites
Trial code
Registry title
Physician-Modified Fenestrated and Branched Aortic Endografting for TAAA
Status
Recruiting
People taking part
80 people, planned
Started
22 Apr 2020
Expected to end
31 Dec 2031
Type of study
Interventional, 2 groups
Treatments tested
  • Physician-modified aortic endograft
Record updated
13 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a large aortic aneurysm (a bulge in the main artery of the chest and belly) who face high risk from open surgery. They get a stent graft changed by the doctor to fit their arteries.

Age
50 to 95 years
Sex
Men and women
Disease stage
Main arm: thoracoabdominal aortic aneurysm of any Crawford extent (I-V), not reaching above the left subclavian artery. Size at least 6.0 cm (2.4 in) in the chest aorta or 5.5 cm in the belly aorta. A second arm also takes chest or belly aortic aneurysms that need coverage of gut or kidney arteries, or aneurysms at high risk of bursting soon. People must be at high risk for open surgery and unable to be treated with an FDA-approved graft. Expected survival over 2 years, apart from the aneurysm.

Main reasons for not taking part

  • Aneurysm caused by dissection, infection, injury or similar causes (main arm); infected aneurysm (second arm)
  • Burst aneurysm or aneurysm causing sudden symptoms (in the second arm: burst with unstable blood pressure)
  • Known connective tissue disorder
  • Artery shape or size on scans that does not allow the device
  • Pregnancy, allergy to device metals or plastics, or unable to take antiplatelet pills by mouth

The registry criteria, word for word

Show all 50 criteriaShow less

Other criteria

  • MAIN ARM - Inclusion Criteria:
  • Must be a man or woman 50 years of age or older by the date of informed consent
  • Must have a thoracoabdominal aortic aneurysm of any Crawford classification (extent I-V) that extends no more proximal than the left subclavian artery
  • Must have an aneurysm size that meets standard indications for surgical repair (6.0 cm in maximum diameter in the descending thoracic aorta, or 5.5 cm in maximum diameter in the abdominal aorta)
  • Must be considered, in the judgment of the S-I, to be a high risk candidate for open surgical repair
  • Must not be a candidate for repair under the Instructions for Use of a commercially available, FDA-approved endovascular graft
  • Must be able to provide informed consent
  • Must be able to comply with the five year study assessment schedule of events
  • Must have a non-aneurysm-related life expectancy, in the judgment of the S-I, of greater than 2 years; MAIN ARM - Exclusion Criteria:
  • Aneurysm due to acute or chronic dissection, intramural hematoma, penetrating aortic ulceration, pseudoaneurysm, mycotic aneurysm, or traumatic transection
  • Ruptured or acutely symptomatic aortic aneurysm
  • Known connective tissue disorder
  • Imaging demonstrating any of the following:; Lack of 20 mm non-aneurysmal proximal seal zone (zone 3, or zone 2 with a carotid-subclavian bypass or transposition); Lack of 15 mm non-aneurysmal distal seal zone(s) (aortic, common iliac, or external iliac); Branch vessel target (renal, superior mesenteric, or celiac) < 5 mm or > 10 mm in average diameter; Untreated left subclavian artery stenosis or occlusion; Untreated unilateral or bilateral hypogastric artery occlusion; Signs that the inferior mesenteric artery is indispensable; Have branching, duplication, aneurysm, or untreatable stenosis of the celiac, superior mesenteric artery, or renal arteries that would preclude implantation of the investigational devices
  • Known sensitivities or allergies to stainless steel, PTFE, polyester, polypropylene, nitinol, or gold
  • History of anaphylaxis to contrast, with inability to prophylax appropriately
  • Have uncorrectable coagulopathy
  • Have unstable angina
  • Have a body habitus that would inhibit X-ray visualization of the aorta
  • Have a major surgical or interventional procedure unrelated to the treatment of the aneurysm planned ≤30 days of the endovascular repair
  • Known to be participating in any other clinical study which may affect performance of this device
  • Known, visible, or suspected pregnancy, confirmed with a Urine Pregnancy Test (UPT)
  • Contraindication to oral antiplatelet therapy
  • Prisoners or those on alternative sentencing
  • Known systemic infection with potential for endovascular graft infection
  • Anticipated need for MRI scanning within 3 months of insertion of investigational product
  • Other conditions or comorbidities that, in the opinion of the S-I, would exclude the patient; EXPANDED ACCESS ARM - Inclusion Criteria
  • Must be a man or woman 50 years of age or older by the date of informed consent
  • Must have a thoracic, thoracoabdominal, or abdominal aortic aneurysm that necessitates coverage of one or more visceral vessels (celiac, superior mesenteric, or renals) for establishment of proximal and/or distal seal
  • Must have an aneurysm size that meets standard size indications for surgical repair (6.0 cm in maximum diameter in the descending thoracic aorta, or 5.5 cm in maximum diameter in the abdominal aorta); or, in the judgment of the S-I, has aneurysm characteristics that portend a high risk of near-term rupture
  • Must be considered, in the judgement of the S-I, to be a high risk candidate for open surgical repair
  • Must not be a candidate for repair under the Instructions for Use of a commercially available, FDA-approved endovascular graft
  • Patient must be able to provide informed consent
  • Must be able to comply with the five year study assessment schedule of events
  • Must have a non-aneurysm-related life expectancy, in the judgement of the S-I, of greater than 2 years; EXPANDED ACCESS ARM - Exclusion Criteria
  • Known or suspected mycotic aneurysm
  • Ruptured aneurysm with hemodynamic instability
  • Known connective tissue disorder
  • Imaging demonstrating any of the following:; Lack of 20 mm non-aneurysmal proximal seal zone (in either native aorta, elephant trunk graft, or aortic arch endograft); Lack of 15 mm non-aneurysmal distal seal zone(s) (in either native aortoiliac vessels, prosthetic aortoiliac grafts, or aortoiliac endografts); Branch vessel target (renal, superior mesenteric, or celiac) > 10 mm in average diameter
  • Known sensitivities or allergies to stainless steel, PTFE, polyester, polypropylene, nitinol, or gold
  • History of anaphylaxis to contrast, with inability to prophylax appropriately
  • Have uncorrectable coagulopathy
  • Have a body habitus that would inhibit X-ray visualization of the aorta
  • Have a major surgical or interventional procedure unrelated to the treatment of the aneurysm planned ≤ 30 days of the endovascular repair
  • Known to be participating in any other clinical study which may affect performance of this device
  • Known, visible, or suspected pregnancy, confirmed with a Urine Pregnancy Test (UPT)
  • Contraindication to oral antiplatelet therapy
  • Prisoners or those on alternative sentencing
  • Known systemic infection with potential for endovascular graft infection
  • Anticipated need for MRI scanning within 3 months of insertion of investigational product
  • Other conditions or comorbidities that, in the opinion of the S-I, would exclude the patient

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 95 years old?

Where in United States

  • Dartmouth Hitchcock Medical CenterLebanon, United StatesContact: David P. Kuwayama, M.D., MPANo longer taking part
  • Yale New Haven HospitalNew Haven, United StatesContact: David Kuwayama, M.D, MPATaking people

About the trial

What the trial wants to find out

The primary clinical objective of this study is to evaluate the safety and effectiveness of a physician-modified, fenestrated and branched aortic endoprosthesis for the treatment of thoracoabdominal aortic aneurysms (TAAAs). The goal of the primary analysis is to demonstrate both the safety and effectiveness of using a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft as compared to previously published results of open surgical replacement of the aneurysmal aorta.

The 2 groups in the trial

  • Main Arm - Physician-modified fenestrated endovascular graftTreatment being tested

    Use of a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft for the endovascular treatment of asymptomatic, non-ruptured thoracoabdominal aortic aneurysms of any Crawford extent (I-V) meeting traditional size criteria for open surgical repair.

    Treatment: Physician-modified aortic endograft

  • Expanded Selection Criteria Arm - Physician-modified fenestrated endovascular graft.Treatment being tested

    Use of a physician-modified fenestrated Cook Zenith Alpha Thoracic Endovascular Graft for the endovascular treatment of asymptomatic, non-ruptured thoracoabdominal, thoracic, or abdominal aortic aneurysms of any Crawford extent (I-V) meeting traditional size criteria for open surgical repair in an expanded use population.

    Treatment: Physician-modified aortic endograft

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal Aortic Aneurysms (TAAA)
Plain-language title
Custom-modified stent graft for aneurysms in the thoracoabdominal aortaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT02989948, who can take part
Record updated
13 August 2026